Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $24.83 Analyst target: $60.16 Upside: 142.29%
uniQure NV, a gene therapy company, is dedicated to developing treatments for patients suffering from genetic and other devastating diseases. The company is headquartered in Amsterdam, the Netherlands.
See the full interactive analysis & chart →Informational only — not investment advice.